×

Lilly Defends Zyprexa Allegations

12:48 PM ET Mon, 18 Dec 2006

Eli Lilly fires back at The New York Times after the paper ran two unfavorable stories about the company's lucrative Schizophrenia drug, Zyprexa. Mike Huckman, CNBC Pharmaceuticals Reporter, has the details.